Stepping down safely: deprescribing gabapentinoids in practice

0
Pregabalin is used beyond its approved indications. Safety concerns means the focus is shifting to individualised deprescribing strategies.

The 6 situations when photo ID is required

0
Checking a patient's photo identification (ID) can be both a useful – and mandatory – practice. Australian Pharmacist explores the instances where minimum practice and...

Tragic case leads to error reporting mechanism recommendation

0
After medicines were delivered to the wrong person, the coroner has recommended a new safety measure to curb inadvertent errors.

Why is my PPI not working?

0
Individual experiencing gastroesophageal reflux symptoms, highlighting the area affected by proton pump inhibitors (PPIs).
An analysis of Pharmaceutical Benefits Scheme (PBS) data in 2019 suggests that a reliance on PPIs for management of reflux symptoms remains.

TGA considers action on widely used flu supplement

0
The TGA is reviewing andrographis after hundreds of serious adverse events raise safety concerns.

When to use Cautionary Advisory Labels

0
Cautionary Advisory Labels (CALs) are applied in addition to the dispensed label at the point of dispensing. The colour and design are intended to...